MedTrace Logo

Trospium Chloride vs Tamsulosin in Treatment of Ureteral Stent Related Symptoms:

NCT03709992 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2023-10-12

No results posted yet for this study

Summary

This study will be conducted to compare the efficacy and safety of Trospium chloride versus Tamsulosin for treatment of ureteral stent related symptoms.

Conditions

  • Ureter Stone
  • Quality of Life
  • Ureter Obstruction

Interventions

DRUG

Trospium Chloride

30 mg of Trospium chloride tablet twice daily

DRUG

Tamsulosin

0.4 mg of Tamsulosin tablet once daily

Sponsors & Collaborators

  • Amiri Hospital

    collaborator OTHER_GOV

  • Mansoura University

    lead OTHER

Principal Investigators

  • Abdullatif AL-Terki, MD · Amiri Hospital - Kuwait

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-18
Primary Completion
2024-08-01
Completion
2024-11-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03709992 on ClinicalTrials.gov